Pharmafile Logo
Pharmafocus logo
Advanced Search

Super surgeries become an election issue

April 26, 2005

Labour plans to create 'super surgeries' designed to grant "entrepreneurial" GPs the opportunity to broaden their scope and offer patients …

News

Bextra withdrawal dents Pfizer’s sales juggernaut

April 22, 2005
Sales and Marketing

The suspension and withdrawal of Pfizer's Cox-II inhibitor Bextra has forced the company to cut its profit forecast for 2005, …

News

PCT mergers won’t solve financial problems, warns report

April 19, 2005

PCT mergers are unlikely to relieve the burden of financial pressures, according to a major report by the NHS Alliance.The …

News

US court rules in favour of Lilly’s Zyprexa

April 18, 2005
Sales and Marketing

Lilly's US patent on blockbuster antipsychotic drug Zyprexa (olanzapine) has been upheld, after a Supreme Court ruled against its generic …

News

Labour makes clinical trials law a manifesto pledge

April 15, 2005
Research and Development

The Labour party has promised to introduce new legislation which would oblige pharmaceutical companies to publish clinical trial data for …

News

Conservatives promise to scrap Strategic Health Authorities and A&E targets

April 14, 2005

News

Novartis signs respiratory deal with UK biotech companies

April 14, 2005
Research and Development

Novartis has signed a deal with two UK biotech companies to develop and market a new treatment for chronic obstructive …

News

Ogilvy reshuffle sweetens Healthworld

April 14, 2005
Medical Communications

The new Ogilvy Healthworld Advertising agency has been launched in the UK following a re-organisation at media communications giant WPP.The …

News

Japanese companies merge to form Astellas

April 13, 2005
Sales and Marketing

News

Eloxatin and Campto gain new NICE approval

April 13, 2005
Sales and Marketing

NICE has recommended two more chemotherapy drugs for the first-line treatment of advanced colorectal cancer.The institute said that Sanofi-Aventis' Eloxatin …

News

Secrets of a youthful brand

April 12, 2005
Sales and Marketing Pan Advertising, Teva, lilly

 Today, more than ever before, the pharmaceutical industry is constantly being reminded that a blockbuster drug’s days are numbered and …

Feature

New depression treatment relieves sleep problems in patients

April 12, 2005
Sales and Marketing

An innovative new depression drug has shown improved benefits over existing treatments, according to data presented by its manufacturer Servier.Valdoxan …

News

The trials of the new PPRS

April 11, 2005

Feature

Serono hit by two late-stage failures

April 8, 2005
Research and Development, Sales and Marketing

Serono has halted development of a late-stage psoriasis drug and stopped another trial for a new skin cancer drug.Both drugs …

News

Bextra suspended from European and US markets

April 8, 2005
Sales and Marketing

News

‘Fundamental misconceptions’ in MP’s report, says industry

April 7, 2005

The ABPI has broadly welcomed the recommendations of the Health Select Committee's investigation into the pharmaceutical industry but has singled …

News

No salesforce purge in Pfizer’s $4 billion cuts

April 7, 2005
Sales and Marketing

Pfizer has set out a $4 billion cost cutting programme for the next three years in an attempt to return …

News

Industry issues warning as UK investment falls

April 6, 2005
Research and Development

News

New hepatitis B treatment approved in US

April 6, 2005
Sales and Marketing

Bristol-Myers Squibb has received US approval for its hepatitis B treatment Baraclude after a six-month priority review.Baraclude (entecavir) is BMS's …

News

Making academic research pay

April 6, 2005
Research and Development

Feature
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026